20 noviembre 2014
Researchers debate whether the lung tissue in pulmonary fibrosis is directly damaged, or whether immune cells initiate the scarring process – an important distinction when trying to find new ways to battle the disease. Now research shows that both processes may be important, and suggest a new direction for developing novel therapies.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/8u4r63jKRXw/141120081756.htm
